Module 3 - PRRT Treatment Pathway
Ivy Vito
In this 20-minute masterclass, Mrs Vito shares best practice from the Royal Free Hospital for 177 Lu-oxodotreotide treatment, focusing on the treatment...
This page is intended for UK healthcare professionals and other relevant decision makers only. If you are a member of the public, please click here.
This portal is funded and owned by Novartis Pharmaceuticals UK Ltd and includes content approved by Novartis.
Adverse events reporting information can be found in the footer of this page.
Ivy Vito
In this 20-minute masterclass, Mrs Vito shares best practice from the Royal Free Hospital for 177 Lu-oxodotreotide treatment, focusing on the treatment...
Royal Free Hospital Team
This 9-minute masterclass provides a detailed demonstration of the equipment that is needed and how the infusion equipment is set up...
Daniel McCool
In this 25-minute masterclass, Mr McCool explains the code of practice and regulations governing nuclear medicine, as well as licences...
Eleni Kalogianni
In this 9-minute masterclass, Ms Kalogianni gives a practical overview of the outpatient approach to PRRT at King’s College Hospital, London,...
Richard Meades
In this 30-minute masterclass, Richard Meades explores the fundamental radioactive characteristics of lutetium-177,...